Update: Shortened interval for postvaccination serologic testing of infants born to hepatitis B-infected mothers

Morbidity and Mortality Weekly Report

Volumn 64, Issue 39, 2015, Pages 1118-1120

  Schillie, Sarah ^a   Murphy, Trudy V ^a   Fenlon, Nancy ^b   Ko, Stephen ^c   Ward, John W ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

BLOOD; FEMALE; HEPATITIS B; HUMAN; IMMUNIZATION; IMMUNOLOGY; INFANT; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY COMPLICATION; PREVENTION AND CONTROL; PUBLIC HEALTH SERVICE; SEROLOGY; TIME; UNITED STATES; VERTICAL TRANSMISSION;

CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION SCHEDULE; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SEROLOGIC TESTS; TIME FACTORS; UNITED STATES;

EID: 84944461092     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: 10.15585/mmwr.mm6439a6     Document Type: Article

References (9)

1. Mast EE, Margolis HS, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep 2005;54(No. RR-16)
2. Smith EA, Jacques-Carroll L, Walker TY, Sirotkin B, Murphy TV. The national Perinatal Hepatitis B Prevention Program, 1994–2008. Pediatrics 2012;129:609–16
3. Kubo A, Shlager L, Marks AR, et al. Prevention of vertical transmission of hepatitis B: an observational study. Ann Intern Med 2014;160:828–35
4. CDC. Postvaccination serologic testing results for infants aged ≤24 months exposed to hepatitis B virus at birth: United States, 2008–2011. MMWR Morb Mortal Wkly Rep 2012;61:768–71
5. Schillie SF, Murphy TV. Seroprotection after recombinant hepatitis B vaccination among newborn infants: a review. Vaccine 2013;31:2506–16
6. Schillie S, Murphy TV, Sawyer M, et al. CDC guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management. MMWR Recomm Rep 2013;62(No. RR-10)
7. Leuridan E, Van Damme P. Hepatitis B and the need for a booster dose. Clin Infect Dis 2011;53:68–75
8. Euler GL, Copeland JR, Rangel MC, Williams WW. Antibody response to postexposure prophylaxis in infants born to hepatitis B surface antigenpositive women. Pediatr Infect Dis J 2003;22:123–9
9. Ko SC, Schillie SF, Walker T, et al. Hepatitis B vaccine response among infants born to hepatitis B surface antigen-positive women. Vaccine 2014;32:2127–33.